A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Clinical trial NCT01944839 · TERMINATED

Trial details

NCT number: NCT01944839
Sponsor: Ophthotech Corporation
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2013-08-01
Primary completion: 2016-12-01
Enrollment: 619

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.